Publications by authors named "Victoria Sinibaldi"

Claim this Profile
A
Abscopal effect following checkpoint inhibitor therapy and localized radiotherapy for metastatic clear cell renal cell carcinoma: A case report.
Ardit Feinaj, Evan Fox, Victoria Sinibaldi, Lawrence Kleinberg, Yasser Ged

Urol Case Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Mark C Markowski, Mary-Ellen Taplin, Rahul Aggarwal, Laura A Sena, Hao Wang, Victoria Sinibaldi

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts.
Mark C Markowski, Hao Wang, Rana Sullivan, Irina Rifkind, Victoria Sinibaldi

Eur Urol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy.
Laura A Sena, Hao Wang, Su J Lim ScM, Irina Rifkind, Nduku Ngomba, Victoria Sinibaldi

Eur J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Cancer: Toxicity Management, Symptom Control, and Palliative Care.
Victoria J Sinibaldi, Caroline F Pratz, Olga Yankulina

J Clin Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Benjamin A Teply, Hao Wang, Brandon Luber, Rana Sullivan, Irina Rifkind, Victoria Sinibaldi

Lancet Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma.
Daniel Keizman, Maya Ish-Shalom, Avishay Sella, Maya Gottfried, Natalie Maimon, Victoria Sinibaldi

Clin Genitourin Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib.
Daniel Keizman, David Sarid, Jae L Lee, Avishay Sella, Maya Gottfried, Victoria Sinibaldi

Oncologist· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies.
Rosa Nadal, Hua-Ling Tsai, Victoria J Sinibaldi, Channing J Paller, Emmanuel S Antonarakis

Prostate· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
Daniel Keizman, Keren Rouvinov, Avishay Sella, Maya Gottfried, Natalie Maimon, Victoria Sinibaldi

Cancer Res Treat· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Cancer Society prostate cancer survivorship care guidelines.
Ted A Skolarus, Andrew M D Wolf, Nicole L Erb, Durado D Brooks, Brian M Rivers, Victoria J Sinibaldi

CA Cancer J Clin· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.
Avivit Peer, Maya Gottfried, Victoria Sinibaldi, Michael A Carducci, Mario A Eisenberger

Prostate· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib.
Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, Natalie Maimon, Avivit Peer, Victoria Sinibaldi

Oncologist· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram.
Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, Natalie Maimon, Avivit Peer, Victoria Sinibaldi

Oncologist· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma.
Daniel Keizman, Maya Ish-Shalom, Roberto Pili, Hans Hammers, Mario A Eisenberger, Victoria Sinibaldi

Eur J Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer.
Jianqing Lin, Victoria J Sinibaldi, Michael A Carducci, Samuel Denmeade, Danny Song

Urol Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivation.
Daniel Keizman, Peng Huang, Emmanuel S Antonarakis, Victoria Sinibaldi, Michael A Carducci

Prostate· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study.
Daniel Keizman, Marianna Zahurak, Victoria Sinibaldi, Michael Carducci, Samuel Denmeade

Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel treatment in the elderly patient with hormone refractory prostate cancer.
Victoria J Sinibaldi

Clin Interv Aging· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint.
Connie Collins, Michael A Carducci, Mario A Eisenberger, John T Isaacs, Alan W Partin, Victoria J Sinibaldi

Cancer Biol Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy.
Gopal K Bajaj, Zhe Zhang, Elizabeth Garrett-Mayer, Renee Drew, Victoria Sinibaldi

Urology· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma.
Victoria J Sinibaldi, Kathy Elza-Brown, Jill Schmidt, Mario A Eisenberger, Eli Rosenbaum

Am J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of cytotoxic chemotherapy in prostate cancer. A critical reevaluation 20 years later.
Mario A Eisenberger, Victoria W Sinibaldi

Oncology (Williston Park)· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial.
Eli Rosenbaum, Marianna Zahurak, Victoria Sinibaldi, Michael A Carducci, Roberto Pili

Clin Cancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of temozolomide and IFN-alpha in patients with advanced renal cell carcinoma.
Usha Sunkara, Janet R Walczak, Lori Summerson, Theresa Rogers, Mario Eisenberger, Victoria Sinibaldi

J Interferon Cytokine Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis